Tetraphase Pharmaceuticals Inc., (Tetraphase) is a clinical-stage life science company with a groundbreaking synthetic chemistry technology platform that has the power to deliver solutions to the global health crisis caused by antibiotic resistance. Tetraphase developed a robust antibiotic franchise that offers the potential to dramatically improve the treatment of both broad and selective spectrum bacterial infections. Tetracyclines are proven antibacterial agents and represent one of the most trusted classes of antibiotics. Tetraphase is rapidly advancing its clinical pipeline of potent novel antibiotics. In terms of spectrum, potency, efficacy, safety and dosing convenience/flexibility, Tetraphase’s pipeline offers significant differentiation from currently marketed products for the treatment of serious infections as well as from those in development by other companies. The company’s was founded in 2006.